Cannara Biotech (OTCMKTS:CNBTF) Stock Price Up 4.6% – Still a Buy?

Cannara Biotech (OTCMKTS:CNBTF)’s stock price rose 4.6% on Friday . The company traded as high as $1.3820 and last traded at $1.37. Approximately 7,023 shares traded hands during trading, a decline of 79% from the average daily volume of 33,127 shares. The stock had previously closed at $1.31.

Cannara Biotech Stock Up 4.6%

The company’s 50 day moving average is $1.31 and its 200 day moving average is $1.28.

Cannara Biotech Holdings Inc (OTCMKTS:CNBTF) is a biotechnology and natural health company focused on the development, production and distribution of plant-derived formulations, including cannabinoid-based products. Headquartered in Canada, the company integrates research and development with large-scale extraction and formulation processes to serve the pharmaceutical, cosmetic and wellness industries.

The company’s offerings comprise high-purity botanical extracts, nutraceutical ingredients and cosmetic actives developed using proprietary extraction and purification techniques.